Cargando…
Primary peripheral T-cell central nervous system lymphoma
BACKGROUND: Primary peripheral T-cell central nervous system lymphoma (PCNSL) is a rare, aggressive tumor that arises in the craniospinal axis and has an increased risk in individuals who are immunocompromised. This lesion often mimics other benign and malignant processes on radiographic imaging, le...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492444/ https://www.ncbi.nlm.nih.gov/pubmed/34621580 http://dx.doi.org/10.25259/SNI_224_2021 |
_version_ | 1784578932375289856 |
---|---|
author | Bird, Cylaina E. Traylor, Jeffrey I. Thomas, Jenna Caruso, James P. Kafka, Benjamin Rosado, Flavia Blackburn, Kyle M. Hatanpaa, Kimmo J. Abdullah, Kalil G. |
author_facet | Bird, Cylaina E. Traylor, Jeffrey I. Thomas, Jenna Caruso, James P. Kafka, Benjamin Rosado, Flavia Blackburn, Kyle M. Hatanpaa, Kimmo J. Abdullah, Kalil G. |
author_sort | Bird, Cylaina E. |
collection | PubMed |
description | BACKGROUND: Primary peripheral T-cell central nervous system lymphoma (PCNSL) is a rare, aggressive tumor that arises in the craniospinal axis and has an increased risk in individuals who are immunocompromised. This lesion often mimics other benign and malignant processes on radiographic imaging, leading to misdiagnosis and delays in treatment. We present a case of a patient with a history of Sjögren’s syndrome and progressive neurologic symptoms who underwent craniotomy for diagnosis. CASE DESCRIPTION: A 61-year-old woman with a history of Sjögren’s syndrome, progressive aphasia, left facial droop, and right-sided paresthesias for 4 months presented for evaluation and management. An enhancing, infiltrative lesion in the left frontal lobe with underlying vasogenic edema was appreciated and suggestive of a primary or metastatic neoplasm. The patient underwent an open biopsy for further evaluation of the lesion. Extensive histopathologic evaluation revealed a diagnosis of T-cell PCNSL. The patient was started on induction methotrexate and temozolomide followed by consolidative radiotherapy. CONCLUSION: Autoimmune conditions are a risk factor for T-cell PCNSL development. T-cell PCNSL has radiographic and gross histologic features that are consistent with a broad differential, including gliomas and inflammatory processes. Prompt diagnosis and extensive histopathological evaluation is essential to ensure appropriate treatment. |
format | Online Article Text |
id | pubmed-8492444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-84924442021-10-06 Primary peripheral T-cell central nervous system lymphoma Bird, Cylaina E. Traylor, Jeffrey I. Thomas, Jenna Caruso, James P. Kafka, Benjamin Rosado, Flavia Blackburn, Kyle M. Hatanpaa, Kimmo J. Abdullah, Kalil G. Surg Neurol Int Case Report BACKGROUND: Primary peripheral T-cell central nervous system lymphoma (PCNSL) is a rare, aggressive tumor that arises in the craniospinal axis and has an increased risk in individuals who are immunocompromised. This lesion often mimics other benign and malignant processes on radiographic imaging, leading to misdiagnosis and delays in treatment. We present a case of a patient with a history of Sjögren’s syndrome and progressive neurologic symptoms who underwent craniotomy for diagnosis. CASE DESCRIPTION: A 61-year-old woman with a history of Sjögren’s syndrome, progressive aphasia, left facial droop, and right-sided paresthesias for 4 months presented for evaluation and management. An enhancing, infiltrative lesion in the left frontal lobe with underlying vasogenic edema was appreciated and suggestive of a primary or metastatic neoplasm. The patient underwent an open biopsy for further evaluation of the lesion. Extensive histopathologic evaluation revealed a diagnosis of T-cell PCNSL. The patient was started on induction methotrexate and temozolomide followed by consolidative radiotherapy. CONCLUSION: Autoimmune conditions are a risk factor for T-cell PCNSL development. T-cell PCNSL has radiographic and gross histologic features that are consistent with a broad differential, including gliomas and inflammatory processes. Prompt diagnosis and extensive histopathological evaluation is essential to ensure appropriate treatment. Scientific Scholar 2021-09-13 /pmc/articles/PMC8492444/ /pubmed/34621580 http://dx.doi.org/10.25259/SNI_224_2021 Text en Copyright: © 2021 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Bird, Cylaina E. Traylor, Jeffrey I. Thomas, Jenna Caruso, James P. Kafka, Benjamin Rosado, Flavia Blackburn, Kyle M. Hatanpaa, Kimmo J. Abdullah, Kalil G. Primary peripheral T-cell central nervous system lymphoma |
title | Primary peripheral T-cell central nervous system lymphoma |
title_full | Primary peripheral T-cell central nervous system lymphoma |
title_fullStr | Primary peripheral T-cell central nervous system lymphoma |
title_full_unstemmed | Primary peripheral T-cell central nervous system lymphoma |
title_short | Primary peripheral T-cell central nervous system lymphoma |
title_sort | primary peripheral t-cell central nervous system lymphoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492444/ https://www.ncbi.nlm.nih.gov/pubmed/34621580 http://dx.doi.org/10.25259/SNI_224_2021 |
work_keys_str_mv | AT birdcylainae primaryperipheraltcellcentralnervoussystemlymphoma AT traylorjeffreyi primaryperipheraltcellcentralnervoussystemlymphoma AT thomasjenna primaryperipheraltcellcentralnervoussystemlymphoma AT carusojamesp primaryperipheraltcellcentralnervoussystemlymphoma AT kafkabenjamin primaryperipheraltcellcentralnervoussystemlymphoma AT rosadoflavia primaryperipheraltcellcentralnervoussystemlymphoma AT blackburnkylem primaryperipheraltcellcentralnervoussystemlymphoma AT hatanpaakimmoj primaryperipheraltcellcentralnervoussystemlymphoma AT abdullahkalilg primaryperipheraltcellcentralnervoussystemlymphoma |